CVM (CEL-SCI Corporation) סך נכסי החברה

CEL-SCI Corporation (CVM) is managed by a stable executive team ensuring transparency across all legal and medical processes. The market trend of the asset shown on this price chart reflects total assets at 20.84. The company is developing a closed-loop environment for head and neck cancer therapy, where customer retention is maximized, although expansion is constrained by stringent FDA requirements. Business revenues are based on the implementation of Multikine through partnerships with surgeons and insurers.

This indicator reflects the total volume of resources of CEL-SCI Corporation (CVM), combining equity and liabilities through a reverse calculation of return on assets (ROA). By analyzing the gross assets metric, investors assess capital management efficiency, which is critical for CEL-SCI Corporation (CVM) when financing costly developments of immunotherapy drugs to combat head and neck oncology.